[go: up one dir, main page]

NO983860D0 - New triazolopurins, processes for their preparation and their use as drugs - Google Patents

New triazolopurins, processes for their preparation and their use as drugs

Info

Publication number
NO983860D0
NO983860D0 NO983860A NO983860A NO983860D0 NO 983860 D0 NO983860 D0 NO 983860D0 NO 983860 A NO983860 A NO 983860A NO 983860 A NO983860 A NO 983860A NO 983860 D0 NO983860 D0 NO 983860D0
Authority
NO
Norway
Prior art keywords
triazolopurins
drugs
processes
preparation
new
Prior art date
Application number
NO983860A
Other languages
Norwegian (no)
Other versions
NO983860L (en
Inventor
Fner-M Hl Ulrike K
Werner Kummer
Gerald Pohl
Wolfram Gaida
Erich Lehr
Joachim Mierau
Thomas Weiser
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002242097A external-priority patent/CA2242097C/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO983860D0 publication Critical patent/NO983860D0/en
Publication of NO983860L publication Critical patent/NO983860L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO983860A 1996-07-20 1998-08-21 Novel triazolopurins, their method of preparation and their use as drugs NO983860L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19629378A DE19629378A1 (en) 1996-07-20 1996-07-20 New triazolopurines, process for their preparation and their use as medicaments
PCT/EP1997/003841 WO1998003511A1 (en) 1996-07-20 1997-07-17 New triazolopurines, method of preparing them and their use as drugs
CA002242097A CA2242097C (en) 1996-07-20 1998-06-26 Imidazotriazolopyrimidines, process for preparing them and their use as pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO983860D0 true NO983860D0 (en) 1998-08-21
NO983860L NO983860L (en) 1998-10-21

Family

ID=32963000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983860A NO983860L (en) 1996-07-20 1998-08-21 Novel triazolopurins, their method of preparation and their use as drugs

Country Status (25)

Country Link
EP (2) EP0880524B1 (en)
JP (1) JP3020281B2 (en)
CN (1) CN1219936A (en)
AT (1) ATE191913T1 (en)
AU (1) AU3695597A (en)
BG (1) BG102707A (en)
BR (1) BR9710747A (en)
CA (1) CA2256736A1 (en)
CZ (1) CZ265498A3 (en)
DE (2) DE19629378A1 (en)
DK (1) DK0880524T3 (en)
EE (1) EE9800451A (en)
ES (1) ES2147453T3 (en)
GR (1) GR3033842T3 (en)
HR (1) HRP970395A2 (en)
HU (1) HUP9902311A3 (en)
ID (1) ID19106A (en)
IL (1) IL126453A0 (en)
NO (1) NO983860L (en)
PL (1) PL328824A1 (en)
PT (1) PT880524E (en)
SK (1) SK114498A3 (en)
TR (1) TR199801659T2 (en)
WO (1) WO1998003511A1 (en)
ZA (1) ZA976331B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826843A1 (en) * 1998-06-16 1999-12-23 Boehringer Ingelheim Pharma Novel imidazotriazolopyrimidines, process for their preparation and their use as medicaments
US6492377B1 (en) 1998-06-25 2002-12-10 Boehringer Ingelheim Pharma Kg Imidazotriazolopyrimidines with adenosine-antagonistic activity
WO2000012511A1 (en) * 1998-08-27 2000-03-09 Boehringer Ingelheim Pharma Kg Imidazotriazolopyrimidines
US7329668B2 (en) 2003-02-25 2008-02-12 Bristol-Myers Squibb Company Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
US7071333B2 (en) 2003-07-30 2006-07-04 Bristol-Myers Squibb Company Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
BRPI0713619A2 (en) 2006-06-23 2013-01-15 Incyte Corp compound or prodrug or pharmaceutically acceptable salt thereof, composition, and use of the compound.
MX2020008949A (en) 2018-02-27 2021-01-08 Incyte Corp Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors.
JP7391046B2 (en) 2018-05-18 2023-12-04 インサイト・コーポレイション Fused pyrimidine derivatives as A2A/A2B inhibitors
IL279829B2 (en) 2018-07-05 2025-05-01 Incyte Holdings Corp Fused pyrazine derivatives as a2a / a2b inhibitors
JOP20210116A1 (en) 2018-11-30 2023-01-30 Merck Sharp & Dohme 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
TWI829857B (en) 2019-01-29 2024-01-21 美商英塞特公司 Pyrazolopyridines and triazolopyridines as a2a / a2b inhibitors
CN112778311B (en) * 2019-11-01 2024-06-04 上海翰森生物医药科技有限公司 Nitrogen-containing cyclic derivative inhibitor, preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA902282B (en) * 1989-03-29 1990-12-28 Merrell Dow Pharma Selective adenosine receptor compounds
IT1264901B1 (en) * 1993-06-29 1996-10-17 Schering Plough S P A HETEROCYCLIC ANALOGUES OF 1,2,4-TRIAZOLE(15-C)PYRIMIDINES WITH ANTAGONIST ACTIVITY FOR THE ADENOSINE A2 RECEPTOR
JPH083169A (en) * 1994-06-15 1996-01-09 Yamasa Shoyu Co Ltd 4-Methyl-1H- [1,2,4] triazolo [1,5-a] purin-9 (4H) -ones

Also Published As

Publication number Publication date
EP0978517A3 (en) 2003-11-12
JP2000501420A (en) 2000-02-08
ZA976331B (en) 1999-01-25
DK0880524T3 (en) 2000-07-17
EP0880524A1 (en) 1998-12-02
ID19106A (en) 1998-06-18
SK114498A3 (en) 1999-02-11
BG102707A (en) 1999-09-30
IL126453A0 (en) 1999-08-17
CZ265498A3 (en) 1998-12-16
DE59701467D1 (en) 2000-05-25
DE19629378A1 (en) 1998-01-29
GR3033842T3 (en) 2000-10-31
CN1219936A (en) 1999-06-16
PT880524E (en) 2000-07-31
NO983860L (en) 1998-10-21
EP0880524B1 (en) 2000-04-19
ES2147453T3 (en) 2000-09-01
PL328824A1 (en) 1999-02-15
EE9800451A (en) 1999-06-15
ATE191913T1 (en) 2000-05-15
BR9710747A (en) 1999-08-17
HUP9902311A3 (en) 2000-06-28
TR199801659T2 (en) 1998-12-21
CA2256736A1 (en) 1998-01-29
HRP970395A2 (en) 1998-08-31
AU3695597A (en) 1998-02-10
EP0978517A2 (en) 2000-02-09
JP3020281B2 (en) 2000-03-15
HUP9902311A2 (en) 1999-10-28
WO1998003511A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
NO954942D0 (en) New erythromycin derivatives, processes for their preparation and use of the derivatives as drugs
NO991815D0 (en) Oxadiazoles, processes for their preparation and their use as drugs
NO964654L (en) New erythromycin derivatives, processes for their preparation and their use as pharmaceuticals
NO20014013D0 (en) 16-halogenepotilone derivatives, processes for their preparation and their pharmaceutical use
NO993003L (en) Sulfonamide derivatives, processes for their preparation and their use as medicaments
DK0885234T3 (en) New erythromycin derivatives, methods for their preparation and their use as pharmaceuticals
DK0966454T3 (en) Disubstituted bicyclic heterocycles, their preparation and their use as drugs
NO20011503D0 (en) Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, their preparation and use as anorectic drugs
NO20013242D0 (en) Benzopyrans and benzoxepines, pharmaceutical compositions comprising them, and processes for their preparation
NO20000294L (en) Derivatives of acylpiperazinylpyrimidines, their preparation and use as pharmaceuticals
NO20005146L (en) Thienylazolylalkoxyethanamines, their preparation and their use as drugs
DK1045856T3 (en) Novel aromatic amides, processes for their preparation and their use as pharmaceuticals
NO985671D0 (en) New Thiazolidinedione-2 derivatives which are 4-diketone substituted, process for their preparation and pharmaceutical preparations containing them
DK1016669T3 (en) New erythromycin derivatives, processes for their preparation and their use as pharmaceuticals
DK1004592T3 (en) New erythromycin derivatives, their preparation and their use as drugs
DK1015421T3 (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals
NO983261D0 (en) New Benzoylguanidine Derivatives, Methods of Preparing Them and Using Them in the Preparation of Medicines
NO983860D0 (en) New triazolopurins, processes for their preparation and their use as drugs
DK0946567T3 (en) New Camptothecin Analog Compounds, Their Use as Drugs and Pharmaceuticals Containing Them
DK1210348T3 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them
NO20010219L (en) Polycyclic thiazolidin-2-ylidenamines, process for their preparation and their use as a drug
DK0906326T3 (en) New aromatic derivatives substituted by a ribose, process for their preparation and their use as drugs
DK0931088T3 (en) New erythromycin compounds, process for their preparation, and their use as drugs
DK1053224T3 (en) Biphenylfulphonylcyanamides, process for their preparation and use thereof as a drug
DK0763535T3 (en) Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as central nervous system active compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application